BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Policy

  Why FDA Delay on Brodalumab is Actually Great News For Valeant

  November 30, 2016

   · 

  1 min read
• 

  Biotech Bay

  A Look at the Top 5 Biotech Stock Performers of 2016

  November 30, 2016

   · 

  2 min read
• 

  Drug Development

  CytRx Plans to File NDA for Once-Failed Sarcoma Drug While Columnist Raises Questions Over Efficacy and CEO Salary Amid Struggle

  November 30, 2016

   · 

  3 min read
• Deals

  Holding Onto Billions, Astellas CEO Hunts for Next Blockbuster

  November 30, 2016

   · 

  1 min read
• Policy

  Senator Ticked Off as Mylan CEO Agrees to Speak at Industry Conference But Not Testify Before Congress

  November 30, 2016

   · 

  1 min read
• Policy

  Gutsy Anti-Vaccine Activists Spot An Ally In The Oval Office

  November 30, 2016

   · 

  1 min read
• BioCapital

  Infection-Related Deaths Expose Deficiencies In FDA Oversight Of Medical Devices

  November 30, 2016

   · 

  1 min read
• 

  Business

  Warp Drive Bio Hands Over Antibiotics Program to Sanofi

  November 30, 2016

   · 

  3 min read
• Biotech Bay

  How Paul Allen’s Foray Into Gene Editing Could Benefit Human Health

  November 30, 2016

   · 

  1 min read
• Policy

  Congress Poised To Pass Sweeping Law Covering FDA And NIH

  November 30, 2016

   · 

  1 min read